Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment
- Sub-Industry: Health Care Equipment
- Symbol: NASDAQ:MASI
- CUSIP: 57479510
- Web: www.masimo.com
Capitalization:- Market Cap: $4.91951 billion
- Outstanding Shares: 51,144,000
Average Prices:- 50 Day Moving Avg: $92.09
- 200 Day Moving Avg: $87.67
- 52 Week Range: $51.10 - $104.71
P/E:- Trailing P/E Ratio: 16.64
- Foreward P/E Ratio: 38.94
- P/E Growth: 1.83
Sales & Book Value:- Annual Revenue: $709.76 million
- Price / Sales: 6.93
- Book Value: $12.40 per share
- Price / Book: 7.76
Profitability:- EBIDTA: $171.03 million
- Net Margins: 44.86%
- Return on Equity: 24.19%
- Return on Assets: 15.00%
Debt:- Current Ratio: 2.74%
- Quick Ratio: 2.35%
Misc:- Average Volume: 623,436 shs.
- Beta: 0.8
- Short Ratio: 6.28
Frequently Asked Questions for Masimo Corporation (NASDAQ:MASI)
What is Masimo Corporation's stock symbol?
Masimo Corporation trades on the NASDAQ under the ticker symbol "MASI."
How were Masimo Corporation's earnings last quarter?
Masimo Corporation (NASDAQ:MASI) issued its quarterly earnings results on Wednesday, May, 3rd. The company reported $0.82 EPS for the quarter, topping the consensus estimate of $0.60 by $0.22. The company earned $186.30 million during the quarter, compared to analyst estimates of $184.14 million. Masimo Corporation had a net margin of 44.86% and a return on equity of 24.19%. The firm's revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.53 EPS. View Masimo Corporation's Earnings History.
What guidance has Masimo Corporation issued on next quarter's earnings?
Masimo Corporation updated its FY17 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of $2.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.33. The company issued revenue guidance of $759 million, compared to the consensus revenue estimate of $753.06 million.
Where is Masimo Corporation's stock going? Where will Masimo Corporation's stock price be in 2017?
7 brokers have issued 1 year price targets for Masimo Corporation's shares. Their forecasts range from $55.00 to $112.00. On average, they expect Masimo Corporation's share price to reach $87.40 in the next twelve months. View Analyst Ratings for Masimo Corporation.
Who are some of Masimo Corporation's key competitors?
Some companies that are related to Masimo Corporation include Jazz Pharmaceuticals PLC (JAZZ), Varian Medical Systems (VAR), Teleflex Incorporated (TFX), Alkermes PLC (ALKS), WellCare Health Plans (WCG), Exelixis (EXEL), Seattle Genetics (SGEN), Qiagen N.V. (QGEN), VCA (WOOF), Alnylam Pharmaceuticals (ALNY), Envision Healthcare Corporation (EVHC), TESARO (TSRO), Dr. Reddy's Laboratories Ltd (RDY), William Demant Holdings (WILYY), Ionis Pharmaceuticals (IONS), STERIS PLC (STE), Bio-Rad Laboratories (BIO) and West Pharmaceutical Services (WST).
Who are Masimo Corporation's key executives?
Masimo Corporation's management team includes the folowing people:
- Joseph E. Kiani, Chairman of the Board, Chief Executive Officer
- Mark P. de Raad, Chief Financial Officer, Executive Vice President - Finance
- Jon Coleman, President - Worldwide Sales, Professional Services and Medical Affairs
- Rick Fishel, President - Worldwide OEM Business & Strategic Development
- Anand Sampath, Chief Operating Officer
- Yongsam Lee, Executive Vice President, Chief Information Officer
- Tom McClenahan, Executive Vice President, General Counsel, Corporate Secretary
- Steven J. Barker M.D., Ph.D., Director
- Sanford Fitch, Independent Director
- Thomas Harkin, Independent Director
Who owns Masimo Corporation stock?
Masimo Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Rockefeller Financial Services Inc. (0.64%), BTIM Corp. (0.43%), Bank of Montreal Can (0.22%), Aperio Group LLC (0.12%), Capital One National Association (0.05%) and State Treasurer State of Michigan (0.04%). Company insiders that own Masimo Corporation stock include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo Corporation.
Who sold Masimo Corporation stock? Who is selling Masimo Corporation stock?
Masimo Corporation's stock was sold by a variety of institutional investors in the last quarter, including BTIM Corp., Rockefeller Financial Services Inc., Capital Impact Advisors LLC, Independent Portfolio Consultants Inc., Meeder Asset Management Inc., Adams Diversified Equity Fund Inc., Narus Financial Partners LLC and First Quadrant L P CA. Company insiders that have sold Masimo Corporation stock in the last year include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Thomas Samuel Mcclenahan and Yongsam Lee. View Insider Buying and Selling for Masimo Corporation.
Who bought Masimo Corporation stock? Who is buying Masimo Corporation stock?
Masimo Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Aperio Group LLC, Legato Capital Management LLC, NN Investment Partners Holdings N.V., Oakbrook Investments LLC, First Citizens Bank & Trust Co., Quantitative Systematic Strategies LLC and Capital One National Association. View Insider Buying and Selling for Masimo Corporation.
How do I buy Masimo Corporation stock?
Shares of Masimo Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Masimo Corporation's stock price today?
One share of Masimo Corporation stock can currently be purchased for approximately $96.19.
MarketBeat Community Rating for Masimo Corporation (NASDAQ MASI)MarketBeat's community ratings are surveys of what our community members think about Masimo Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Masimo Corporation (NASDAQ:MASI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 4 Hold Ratings, 3 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.43) |
| Consensus Price Target: | $87.40 (9.14% downside) |
Analysts' Ratings History for Masimo Corporation (NASDAQ:MASI)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/19/2017 | Roth Capital | Boost Price Target | Buy | $96.00 -> $105.00 | Low |  |
| 7/10/2017 | Stifel Nicolaus | Initiated Coverage | Buy | $105.00 | High | |
| 5/22/2017 | Wedbush | Reiterated Rating | Outperform | $112.00 | Low | |
| 3/16/2017 | Piper Jaffray Companies | Downgrade | Overweight -> Neutral | | High | |
| 2/13/2017 | Raymond James Financial, Inc. | Downgrade | Outperform -> Market Perform | | N/A | |
| 2/13/2017 | Citigroup Inc. | Downgrade | Market Perform | $60.00 | N/A | |
| 8/5/2016 | BTIG Research | Reiterated Rating | Hold | | N/A | |
(Data available from 7/24/2015 forward)
Earnings History for Masimo Corporation (NASDAQ:MASI)Earnings History by Quarter for Masimo Corporation (NASDAQ MASI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/3/2017 | Q1 2017 | $0.60 | $0.82 | $184.14 million | $186.30 million | View | Listen | |
| 2/14/2017 | Q416 | $0.52 | $0.51 | $180.48 million | $183.20 million | View | Listen | |
| 11/2/2016 | Q316 | $0.42 | $0.52 | $165.51 million | $167.60 million | View | Listen | |
| 8/3/2016 | Q216 | $0.41 | $0.57 | $166.02 million | $172.64 million | View | Listen | |
| 5/4/2016 | Q116 | $0.43 | $0.53 | $165.25 million | $171.20 million | View | Listen | |
| 2/23/2016 | Q415 | $0.39 | $0.15 | $164.25 million | $167.30 million | View | Listen | |
| 11/5/2015 | Q315 | $0.31 | $0.36 | $149.31 million | $152.60 million | View | Listen | |
| 8/4/2015 | Q215 | $0.32 | $0.43 | $147.93 million | $155.73 million | View | Listen | |
| 5/6/2015 | Q115 | $0.35 | $0.41 | $151.00 million | $154.54 million | View | Listen | |
| 2/17/2015 | Q414 | $0.37 | $0.40 | $159.45 million | $161.80 million | View | Listen | |
| 10/29/2014 | Q314 | $0.25 | $0.27 | $144.20 million | $144.10 million | View | Listen | |
| 8/7/2014 | Q214 | $0.29 | $0.27 | $145.76 million | $140.92 million | View | Listen | |
| 4/30/2014 | Q114 | $0.29 | $0.39 | $144.01 million | $139.80 million | View | Listen | |
| 2/13/2014 | Q413 | $0.31 | $0.31 | $148.25 million | $134.70 million | View | Listen | |
| 10/30/2013 | Q313 | $0.26 | $0.27 | $132.47 million | $131.40 million | View | Listen | |
| 7/31/2013 | Q2 2013 | $0.28 | $0.30 | $136.36 million | $137.42 million | View | Listen | |
| 5/2/2013 | Q1 2013 | $0.28 | $0.28 | $134.46 million | $135.90 million | View | Listen | |
| 2/14/2013 | Q4 2012 | $0.29 | $0.26 | $129.09 million | $132.20 million | View | Listen | |
| 11/1/2012 | Q312 | $0.26 | $0.26 | $120.99 million | $112.10 million | View | N/A | |
| 8/1/2012 | | $0.28 | $0.27 | | | View | N/A | |
| 5/2/2012 | | $0.28 | $0.27 | | | View | N/A | |
| 2/14/2012 | | $0.23 | $0.23 | | | View | N/A | |
| 10/25/2011 | | $0.27 | $0.24 | | | View | N/A | |
| 8/9/2011 | | $0.28 | $0.28 | | | View | N/A | |
| 5/3/2011 | | $0.30 | $0.30 | | | View | N/A | |
| 2/15/2011 | | $0.26 | $0.29 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Masimo Corporation (NASDAQ:MASI)2017 EPS Consensus Estimate: $2.29
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.59 | $0.60 | $0.60 |
| Q2 2017 | 2 | $0.54 | $0.55 | $0.55 |
| Q3 2017 | 2 | $0.51 | $0.53 | $0.52 |
| Q4 2017 | 2 | $0.61 | $0.64 | $0.63 |
(Data provided by Zacks Investment Research)
Dividend History for Masimo Corporation (NASDAQ:MASI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Masimo Corporation (NASDAQ:MASI)Insider Ownership Percentage: 16.60%
Institutional Ownership Percentage: 83.56%
Insider Trades by Quarter for Masimo Corporation (NASDAQ:MASI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 7/14/2017 | Rick Fishel | Insider | Sell | 15,000 | $94.85 | $1,422,750.00 | |
| 7/13/2017 | Sanford Fitch | Director | Sell | 6,000 | $91.89 | $551,340.00 | |
| 7/11/2017 | Anand Sampath | COO | Sell | 40,000 | $92.00 | $3,680,000.00 | |
| 7/11/2017 | Rick Fishel | Insider | Sell | 15,000 | $92.85 | $1,392,750.00 | |
| 6/29/2017 | Sanford Fitch | Director | Sell | 14,000 | $92.06 | $1,288,840.00 | |
| 5/1/2017 | Joe E Kiani | CEO | Sell | 145,841 | $102.37 | $14,929,743.17 | |
| 4/28/2017 | Thomas Samuel Mcclenahan | EVP | Sell | 8,000 | $102.75 | $822,000.00 | |
| 4/26/2017 | Joe E Kiani | CEO | Sell | 154,159 | $99.70 | $15,369,652.30 | |
| 4/25/2017 | Joe E Kiani | CEO | Sell | 13,201 | $101.00 | $1,333,301.00 | |
| 4/25/2017 | Jon Coleman | Insider | Sell | 50,000 | $100.00 | $5,000,000.00 | |
| 4/25/2017 | Yongsam Lee | EVP | Sell | 10,000 | $100.00 | $1,000,000.00 | |
| 4/24/2017 | Joe E Kiani | CEO | Sell | 100,000 | $99.00 | $9,900,000.00 | |
| 4/24/2017 | Thomas Samuel Mcclenahan | EVP | Sell | 10,000 | $98.75 | $987,500.00 | |
| 4/20/2017 | Thomas Samuel Mcclenahan | EVP | Sell | 10,000 | $95.75 | $957,500.00 | |
| 4/19/2017 | Yongsam Lee | EVP | Sell | 10,000 | $95.00 | $950,000.00 | |
| 4/4/2017 | Raad Mark De | CFO | Sell | 48,000 | $93.25 | $4,476,000.00 | |
| 3/22/2017 | Sanford Fitch | Director | Sell | 3,000 | $93.23 | $279,690.00 | |
| 3/10/2017 | Paul Jansen | EVP | Sell | 55,611 | $94.47 | $5,253,571.17 | |
| 3/9/2017 | Ramshorst David J Van | Insider | Sell | 7,500 | $94.20 | $706,500.00 | |
| 2/23/2017 | Raad Mark De | CFO | Sell | 30,000 | $86.25 | $2,587,500.00 | |
| 2/17/2017 | Raad Mark De | CFO | Sell | 45,000 | $80.00 | $3,600,000.00 | |
| 2/16/2017 | Joe E Kiani | CEO | Sell | 300,000 | $80.04 | $24,012,000.00 | |
| 2/3/2017 | Jon Coleman | Insider | Sell | 6,000 | $75.00 | $450,000.00 | |
| 2/3/2017 | Raad Mark De | CFO | Sell | 15,000 | $75.00 | $1,125,000.00 | |
| 1/27/2017 | Jon Coleman | Insider | Sell | 5,800 | $72.50 | $420,500.00 | |
| 1/27/2017 | Raad Mark De | CFO | Sell | 15,000 | $72.50 | $1,087,500.00 | |
| 1/20/2017 | Jon Coleman | Insider | Sell | 200 | $72.50 | $14,500.00 | |
| 1/13/2017 | Yongsam Lee | EVP | Sell | 10,000 | $72.00 | $720,000.00 | |
| 1/10/2017 | Jon Coleman | Insider | Sell | 6,000 | $70.00 | $420,000.00 | |
| 1/10/2017 | Raad Mark De | CFO | Sell | 15,000 | $70.00 | $1,050,000.00 | |
| 1/10/2017 | Yongsam Lee | EVP | Sell | 10,000 | $70.00 | $700,000.00 | |
| 1/9/2017 | Paul Jansen | EVP | Sell | 17,945 | $68.88 | $1,236,051.60 | |
| 1/3/2017 | Ramshorst David J Van | Insider | Sell | 4,000 | $67.20 | $268,800.00 | |
| 12/27/2016 | Paul Jansen | EVP | Sell | 2,055 | $68.88 | $141,548.40 | |
| 12/21/2016 | Jon Coleman | Insider | Sell | 4,000 | $67.50 | $270,000.00 | |
| 12/16/2016 | Thomas Samuel Mcclenahan | EVP | Sell | 10,000 | $66.00 | $660,000.00 | |
| 12/8/2016 | Paul Jansen | EVP | Sell | 10,000 | $63.88 | $638,800.00 | |
| 12/7/2016 | Thomas Samuel Mcclenahan | EVP | Sell | 2,293 | $63.00 | $144,459.00 | |
| 12/6/2016 | Joe E Kiani | CEO | Sell | 52,859 | $62.03 | $3,278,843.77 | |
| 12/6/2016 | Thomas Samuel Mcclenahan | EVP | Sell | 4,000 | $63.00 | $252,000.00 | |
| 12/1/2016 | Joe E Kiani | CEO | Sell | 36,119 | $62.06 | $2,241,545.14 | |
| 11/29/2016 | Joe E Kiani | CEO | Sell | 104,870 | $62.27 | $6,530,254.90 | |
| 11/23/2016 | Joe E Kiani | CEO | Sell | 85,771 | $62.06 | $5,322,948.26 | |
| 11/22/2016 | Joe E Kiani | CEO | Sell | 869 | $62.00 | $53,878.00 | |
| 11/21/2016 | Joe E Kiani | CEO | Sell | 30,462 | $62.04 | $1,889,862.48 | |
| 11/18/2016 | Joe E Kiani | CEO | Sell | 20,381 | $62.02 | $1,264,029.62 | |
| 11/1/2016 | Anand Sampath | COO | Sell | 65,000 | $55.04 | $3,577,600.00 | |
| 10/31/2016 | Anand Sampath | COO | Sell | 51,345 | $55.05 | $2,826,542.25 | |
| 10/19/2016 | Sanford Fitch | Director | Sell | 2,000 | $59.05 | $118,100.00 | |
| 10/10/2016 | Joe E Kiani | CEO | Sell | 84,617 | $60.26 | $5,099,020.42 | |
| 10/10/2016 | Yongsam Lee | EVP | Sell | 30,000 | $60.50 | $1,815,000.00 | |
| 10/5/2016 | Sanford Fitch | Director | Sell | 2,000 | $59.58 | $119,160.00 | |
| 10/4/2016 | Joe E Kiani | CEO | Sell | 4,300 | $60.07 | $258,301.00 | |
| 10/3/2016 | Joe E Kiani | CEO | Sell | 2,200 | $60.00 | $132,000.00 | |
| 9/30/2016 | Thomas Samuel Mcclenahan | EVP | Sell | 10,000 | $59.00 | $590,000.00 | |
| 9/27/2016 | Joe E Kiani | CEO | Sell | 4,464 | $60.01 | $267,884.64 | |
| 9/22/2016 | Joe E Kiani | CEO | Sell | 49,484 | $60.18 | $2,977,947.12 | |
| 9/21/2016 | Sanford Fitch | Director | Sell | 2,000 | $59.41 | $118,820.00 | |
| 9/20/2016 | Joe E Kiani | CEO | Sell | 400 | $60.16 | $24,064.00 | |
| 9/19/2016 | Joe E Kiani | CEO | Sell | 999 | $60.03 | $59,969.97 | |
| 9/7/2016 | Joe E Kiani | CEO | Sell | 33,536 | $60.00 | $2,012,160.00 | |
| 9/7/2016 | Jon Coleman | Insider | Sell | 6,000 | $60.00 | $360,000.00 | |
| 9/7/2016 | Sanford Fitch | Director | Sell | 2,000 | $59.81 | $119,620.00 | |
| 8/17/2016 | Sanford Fitch | Director | Sell | 2,000 | $58.11 | $116,220.00 | |
| 8/4/2016 | Jon Coleman | Insider | Sell | 22,000 | $56.82 | $1,250,040.00 | |
| 8/4/2016 | Paul Jansen | EVP | Sell | 10,000 | $58.88 | $588,800.00 | |
| 8/3/2016 | Sanford Fitch | Director | Sell | 2,000 | $52.62 | $105,240.00 | |
| 7/20/2016 | Rick Fishel | Insider | Sell | 22,000 | $53.85 | $1,184,700.00 | |
| 7/20/2016 | Sanford Fitch | Director | Sell | 3,000 | $53.48 | $160,440.00 | |
| 6/30/2016 | Ramshorst David J Van | CAO | Sell | 5,000 | $52.50 | $262,500.00 | |
| 6/7/2016 | Joe E Kiani | CEO | Sell | 65,048 | $50.00 | $3,252,400.00 | |
| 6/3/2016 | Joe E Kiani | CEO | Sell | 234,952 | $50.09 | $11,768,745.68 | |
| 6/1/2016 | Jon Coleman | Insider | Sell | 4,000 | $50.00 | $200,000.00 | |
| 5/31/2016 | Raad Mark De | CFO | Sell | 40,000 | $49.43 | $1,977,200.00 | |
| 5/25/2016 | Rick Fishel | Insider | Sell | 25,000 | $49.85 | $1,246,250.00 | |
| 5/5/2016 | Jon Coleman | Insider | Sell | 8,000 | $47.00 | $376,000.00 | |
| 4/28/2016 | Paul Jansen | EVP | Sell | 10,000 | $44.88 | $448,800.00 | |
| 4/27/2016 | Jon Coleman | Insider | Sell | 4,000 | $44.00 | $176,000.00 | |
| 3/23/2016 | Yongsam Lee | EVP | Sell | 96,000 | $39.96 | $3,836,160.00 | |
| 3/22/2016 | Yongsam Lee | EVP | Sell | 32,000 | $40.06 | $1,281,920.00 | |
| 3/21/2016 | Yongsam Lee | EVP | Sell | 32,000 | $39.83 | $1,274,560.00 | |
| 3/15/2016 | Raad Mark De | CFO | Sell | 40,000 | $39.00 | $1,560,000.00 | |
| 2/29/2016 | Raad Mark De | CFO | Sell | 40,000 | $38.11 | $1,524,400.00 | |
| 12/24/2015 | Jon Coleman | insider | Sell | 10,000 | $42.00 | $420,000.00 | |
| 12/9/2015 | Sanford Fitch | Director | Sell | 2,000 | $41.00 | $82,000.00 | |
| 11/11/2015 | Sanford Fitch | Director | Sell | 2,000 | $42.67 | $85,340.00 | |
| 11/6/2015 | Anand Sampath | COO | Sell | 45,000 | $42.00 | $1,890,000.00 | |
| 11/6/2015 | Jon Coleman | insider | Sell | 10,000 | $42.38 | $423,800.00 | |
| 10/14/2015 | Sanford Fitch | Director | Sell | 2,000 | $39.29 | $78,580.00 | |
| 9/17/2015 | Paul Jansen | EVP | Sell | 10,000 | $42.88 | $428,800.00 | |
| 9/9/2015 | Sanford Fitch | Director | Sell | 2,000 | $41.29 | $82,580.00 | |
| 8/31/2015 | Thomas Samuel Mcclenahan | EVP | Sell | 22,000 | $40.62 | $893,640.00 | |
| 8/26/2015 | Paul Jansen | EVP | Sell | 10,000 | $40.88 | $408,800.00 | |
| 7/22/2015 | Rick Fishel | Insider | Sell | 35,084 | $41.85 | $1,468,265.40 | |
| 7/21/2015 | Joe E Kiani | CEO | Sell | 300,000 | $40.55 | $12,165,000.00 | |
| 7/21/2015 | Steven Barker | Director | Sell | 20,000 | $40.00 | $800,000.00 | |
| 7/8/2015 | Sanford Fitch | Director | Sell | 2,000 | $38.18 | $76,360.00 | |
| 6/10/2015 | Sanford Fitch | Director | Sell | 2,000 | $36.49 | $72,980.00 | |
| 6/4/2015 | Steven Barker | Director | Sell | 25,000 | $36.20 | $905,000.00 | |
| 4/8/2015 | Sanford Fitch | Director | Sell | 2,000 | $34.57 | $69,140.00 | |
| 2/18/2015 | Rick Fishel | Insider | Sell | 18,170 | $29.85 | $542,374.50 | |
| 5/22/2013 | Robert Coleman | Director | Sell | 59,400 | $21.93 | $1,302,642.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Masimo Corporation (NASDAQ:MASI)
Latest Headlines for Masimo Corporation (NASDAQ:MASI)
| Source: |
|
| Date | Headline |
|---|
 | Masimo Corp. (MASI) Receives CE Marking of Noninvasive RPVi - StreetInsider.com
www.streetinsider.com - July 22 at 6:21 AM |
| Masimo Corp. (MASI) Receives CE Marking of Noninvasive RPVi
www.streetinsider.com - July 21 at 1:56 AM |
 | Masimo's RPVI CE Mark certified; shares up 1%
seekingalpha.com - July 20 at 11:13 AM |
 | Masimo Announces CE Marking of Noninvasive RPVi™, a rainbow® Multi-Wavelength Index of Pleth Variability
finance.yahoo.com - July 20 at 5:54 AM |
| Masimo to Report Second Quarter 2017 Financial Results after Market Close on Wednesday, August 2
finance.yahoo.com - July 20 at 12:51 AM |
 | Masimo Corporation (MASI) Price Target Increased to $105.00 by Analysts at Roth Capital
www.americanbankingnews.com - July 19 at 10:33 AM |
 | Better Buy: Masimo Corporation vs. Zimmer Biomet Holdings Inc.
www.fool.com - July 19 at 10:07 AM |
| Masimo Corporation (MASI) Insider Rick Fishel Sells 15,000 Shares
www.americanbankingnews.com - July 18 at 7:25 PM |
| 3 Stocks the Market Is Missing the Boat On - Motley Fool
www.fool.com - July 16 at 12:52 PM |
| Sanford Fitch Sells 6,000 Shares of Masimo Corporation (MASI) Stock
www.americanbankingnews.com - July 13 at 7:53 PM |
| Masimo Corporation (NASDAQ:MASI) COO Anand Sampath Sells 40,000 Shares
www.americanbankingnews.com - July 13 at 7:52 PM |
| ETFs with exposure to Masimo Corp. : July 12, 2017
finance.yahoo.com - July 13 at 6:35 AM |
| Masimo Corp. (MASI) Receives CE Marking of Rainbow Super Sensor - StreetInsider.com
www.streetinsider.com - July 12 at 2:52 AM |
| Here's Why the Best Is Yet to Come for Masimo Corporation - Motley Fool
www.fool.com - July 12 at 2:52 AM |
| Zacks Investment Research Upgrades Masimo Corporation (NASDAQ:MASI) to Hold
www.americanbankingnews.com - July 11 at 1:46 PM |
 | EEG-EMG Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
www.bizjournals.com - July 11 at 1:13 AM |
| Masimo Corp. (MASI) Receives CE Marking of Rainbow Super Sensor
www.streetinsider.com - July 11 at 1:13 AM |
| Here's Why the Best Is Yet to Come for Masimo Corporation
finance.yahoo.com - July 11 at 1:13 AM |
| Stifel Nicolaus Begins Coverage on Masimo Corporation (MASI)
www.americanbankingnews.com - July 10 at 6:36 PM |
| Here's Why the Best Is Yet to Come for Masimo Corporation
www.fool.com - July 10 at 9:52 AM |
| Masimo Announces CE Marking of rainbow® Super Sensor
finance.yahoo.com - July 10 at 5:14 AM |
| Masimo Corporation (MASI) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 7 at 12:02 PM |
| Masimo Corporation (NASDAQ:MASI) Downgraded to "Hold" at BidaskClub
www.americanbankingnews.com - July 5 at 7:28 PM |
| Masimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : July 4, 2017
finance.yahoo.com - July 4 at 6:39 PM |
| Masimo Corporation (MASI) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - July 4 at 2:06 PM |
 | Medtronic plc (MDT) Ex-Dividend Date Scheduled for July 05, 2017 ... - Nasdaq
www.nasdaq.com - July 4 at 1:06 AM |
| Head-To-Head Survey: Masimo Corporation (MASI) & Penumbra (PEN)
www.americanbankingnews.com - July 3 at 8:25 AM |
| Analysts Anticipate Masimo Corporation (MASI) Will Announce Quarterly Sales of $189.69 Million
www.americanbankingnews.com - June 30 at 1:45 PM |
| Masimo Corporation (MASI)
seekingalpha.com - June 30 at 1:19 AM |
| Form 4 MASIMO CORP For: Jun 27 Filed by: FITCH SANFORD
www.streetinsider.com - June 30 at 1:19 AM |
| Insider Selling: Masimo Corporation (MASI) Director Sells 14,000 Shares of Stock
www.americanbankingnews.com - June 29 at 10:28 PM |
| iRadimed Corporation (IRMD) & Masimo Corporation (MASI) Critical Comparison
www.americanbankingnews.com - June 29 at 8:12 AM |
| Masimo Co. (MASI) Expected to Post Earnings of $0.71 Per Share
www.americanbankingnews.com - June 28 at 4:10 PM |
| ETFs with exposure to Masimo Corp. : June 26, 2017
finance.yahoo.com - June 27 at 2:12 AM |
| First Week of August 18th Options Trading For Masimo (MASI)
www.nasdaq.com - June 21 at 7:34 PM |
| Masimo Corp. breached its 50 day moving average in a Bullish Manner : MASI-US : June 20, 2017
finance.yahoo.com - June 20 at 7:23 PM |
| New Study Compares Performance of Masimo Next Generation SedLine® Patient State Index (PSi) to Original PSi During Anesthesia
finance.yahoo.com - June 19 at 11:44 AM |
| Analyzing Penumbra (PEN) and Masimo Corporation (MASI)
www.americanbankingnews.com - June 19 at 10:33 AM |
| Masimo Corp. :MASI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 7:23 PM |
| Contrasting Masimo Corporation (MASI) & Penumbra (PEN)
www.americanbankingnews.com - June 16 at 12:30 PM |
| ETFs with exposure to Masimo Corp. : June 15, 2017
finance.yahoo.com - June 16 at 7:35 AM |
| Masimo Corporation (MASI) & Penumbra (PEN) Financial Comparison
www.americanbankingnews.com - June 13 at 4:48 PM |
| Masimo (MASI) Presents Utility Study of Oxygen Reserve Index
finance.yahoo.com - June 12 at 3:46 PM |
| Five Sensible Stock Picks Intelligent Investors Should Make
finance.yahoo.com - June 12 at 3:46 PM |
| Masimo Corporation (MASI) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - June 12 at 10:00 AM |
| New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™
finance.yahoo.com - June 12 at 9:28 AM |
| Masimo Corp. breached its 50 day moving average in a Bullish Manner : MASI-US : June 8, 2017
finance.yahoo.com - June 8 at 10:19 AM |
 | BRIEF-Masimo Corp says appears co addressed violations contained in FDA warning letter regarding Irvine facility - Reuters
www.reuters.com - June 7 at 9:18 AM |
| BRIEF-Masimo Corp says appears co addressed violations contained in FDA warning letter regarding Irvine facility
www.reuters.com - June 6 at 9:41 AM |
 | Masimo Announces Limited Market Release of Rad-67™ rainbow ... - Business Wire (press release)
www.businesswire.com - June 6 at 12:07 AM |
Masimo Corporation (MASI) Chart for Monday, July, 24, 2017
